News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ex-Bristol-Myers Squibb Company (BMY) Executive Gets One Year in Prison for Insider Trading



10/24/2013 6:41:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A former Bristol-Myers Squibb Co finance executive who pleaded guilty to insider trading was sentenced on Wednesday to one year and one day in prison, federal prosecutors said. Robert Ramnarine of East Brunswick, New Jersey, admitted in June to one count of securities fraud for trading in Amylin Pharmaceuticals Inc stock options before Bristol-Myers agreed to buy the biotechnology company in June 2012 for $5.3 billion. Prosecutors accused the 46-year-old Ramnarine of making $311,361 of illegal profit from options trading in Amylin and two other companies that Bristol-Myers sought to buy.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Philadelphia Inquirer
Read at News Release
Read at Bloomberg


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES